Read More Pharma Industry News OncoSil wins FDA HDE approval for rare bile duct cancer treatment OncoSil Medical has received U.S. FDA Humanitarian Device Exemption approval for the OncoSil System in unresectable, non-metastatic distal cholangiocarcinoma, opening its first U.S. commercial pathway. bySrinathAugust 23, 2026